Advances in Biomarkers for Detecting Early Cancer Treatment-Related Cardiac Dysfunction
With the gradual prolongation of the overall survival of cancer patients, the cardiovascular toxicity associated with oncology drug therapy and radiotherapy has attracted increasing attention. At present, the main methods to identify early cancer treatment-related cardiac dysfunction (CTRCD) include...
Enregistré dans:
Auteurs principaux: | Huiyu Xiao, Xiaojie Wang, Shuang Li, Ying Liu, Yijie Cui, Xiaoqin Deng |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d8c62d5d835547c9919d7652bbbe34d0 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Assesment of the TEI index of myocardial performance in dogs with doxorubicin-induced cardiomiopathy
par: Sousa,MG, et autres
Publié: (2014) -
Role of Cardiac Biomarkers in Cancer Patients
par: Gennaro Carmine Semeraro, et autres
Publié: (2021) -
Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in the Large Arteries of Lymphoma Patients under 50 Years of Age
par: Raffaella Calabretta, et autres
Publié: (2021) -
Overweight as a Favorable Clinical Biomarker for Checkpoint Inhibitor Therapy Response in Recurrent Gynecologic Cancer Patients
par: Thomas Bartl, et autres
Publié: (2021) -
Cardiac MRI in Immune Checkpoint Inhibitor Associated Pericarditis
par: Can Öztürk, et autres
Publié: (2021)